CELL INTELLIGENCE · 肿瘤细胞治疗研究

γδ T 细胞调节小细胞肺癌中的抗肿瘤免疫

γδ T cells modulate anti-tumor immunity in small cell lung cancer.

从受体生物学到治疗：不同 EGFR 突变在靶向癌症治疗开发中的重要性

From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.

整合 CD28、4-1BB 和 CD27 的三重共刺激 GD2-CAR-T 细胞在实体瘤模型中介导强效细胞毒性并减少耗竭

Triple-costimulatory GD2-CAR T cells incorporating CD28, 4-1BB and CD27 mediate potent cytotoxicity and reduce exhaustion in solid tumour models.

肿瘤免疫治疗中的新抗原：机制、治疗策略和未来展望

Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives.

NSCLC 精准免疫肿瘤学：整合 ADC、治疗性疫苗与过继性细胞治疗用于下一代全身治疗

Precision immuno-oncology in NSCLC: integrating ADCs, therapeutic vaccines, and adoptive cell therapies for next-generation systemic treatment.

非小细胞肺癌中的癌症疫苗策略

Cancer Vaccine Strategies in Non-Small Cell Lung Cancer.

常规实践中晚期 NSCLC 诊断的实用工作流程：整合组织病理学、PD-L1 评分与 EGFR 检测

A pragmatic workflow for advanced NSCLC diagnosis in routine practice: Integrating histopathology, PD-L1 scoring, and EGFR testing.

一种活检层面的反射式工作流程，可在晚期非小细胞肺癌中实现可行且组织高效的同步分子与免疫分析。

靶向胶质母细胞瘤的肿瘤微环境：机制洞察、治疗策略及免疫治疗进展

Targeting the tumor microenvironment in glioblastoma: Mechanistic insights, therapeutic strategies, and advances in immunotherapy.

TMPO-AS1/hsa-let-7b-5p 调控轴塑造肺腺癌的转录异质性和免疫景观

The TMPO-AS1/hsa-let-7b-5p regulatory axis shapes transcriptional heterogeneity and immune landscape in lung adenocarcinoma.

研究得出结论，TMPO-AS1 在 LUAD 病例中过表达，突显其作为 LUAD 分子分类器及与不良临床结局相关的预后生物标志物的潜力。

CAR-NK 细胞生物学与工程化用于实体瘤，重点关注肺癌

CAR-NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer.